|
AU2013201345A1
|
|
Oligodendrocyte precursor cell proliferation regulated by prolactin
|
|
AU2012201397A1
|
|
Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
|
|
CA2693996A1
|
|
Treating or ameliorating neuroinflammatory or demyelinating disorders with prolactin and an immunomodulator
|
|
TW200810774A
|
|
Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents
|
|
CN101405021A
|
|
Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents
|
|
WO2007106986A1
|
|
Dosing regimes for lh or hcg and epo for treatment of neurological disorders
|
|
TW200745335A
|
|
Pregnancy-induced oligodendrocyte precursor cell proliferation regulated by prolactin
|
|
KR20080074108A
|
|
Oligodendrocyte precursor cell proliferation regulated by prolactin
|
|
AU2005312302A1
|
|
Platelet-derived growth factor-responsive neural precursor cells and progeny thereof
|
|
EP1812047A1
|
|
Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
|
|
CN101072579A
|
|
Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
|
|
US2006105958A1
|
|
Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
|
|
AU2005211847A1
|
|
Use of luteinizing hormone (LH) and chorionic gonadotropin (hCG) for proliferation of neural stem cells and neurogenesis
|
